Comunicati Stampa
Salute e Benessere

NCH Becomes First U.S. Hospital to Use AI That Detects Hidden Heart Attack Risk a Decade in Advance

Caristo's FDA-cleared CaRi-Plaque™ technology analyzes coronary CT angiography (CCTA) scans, the first-line test for patients with chest pain, to identify high-risk plaque that may lead to future heart attacks. CaRi-Heart™ is the only technology in the world able to detect and quantify coronary inflammation, an early driver of heart disease, without waiting for patients to develop visible plaque. Caristo's FDA-clearedCaRi-Plaque™technology analyzes coronary CT angiography (CCTA) scans, the...
NAPLES, Fla., (informazione.news - comunicati stampa - salute e benessere)

Caristo's FDA-cleared technology analyzes coronary CT angiography (CCTA) scans, the first-line test for patients with chest pain, to identify high-risk plaque that may lead to future heart attacks. is the only technology in the world able to detect and quantify coronary inflammation, an early driver of heart disease, without waiting for patients to develop visible plaque.

Current clinical pathways often fail to identify high risk patients by missing inflammatory disease activity and relying on plaque assessment alone. In fact, twice as many fatal and non-fatal cardiac events occur in patients without obstructive plaque on CCTA. A major breakthrough, technology provides a risk score to help doctors and patients understand the likelihood of a cardiac event up to 10 years in advance, even in the absence of visible plaque [ Lancet , 2024]. The technology is widely used in Europe and currently under FDA review.

"This NCH-Caristo collaboration represents a new paradigm in cardiovascular medicine," said , Section Head of Cardiac Imaging at NCH Rooney Heart Institute. "Doctors are used to responding to cardiac events after they happen. Caristo has the first clinically validated AI solutions that let us prevent heart attacks a decade before they occur."

NCH is recognized by as one of America's Top 50 Hospitals and among the top three in Florida for cardiac care. Under the new collaboration every NCH Rooney Heart Institute patient who qualifies for plaque analysis will have their CCTA scan analyzed by CaRi-Plaque™. NCH will also deploy CaRi-Heart™ as part of a research program, giving physicians the ability to incorporate the inflammation-based risk score into treatment and outcomes research.

In addition, NCH is launching a new preventive heart health service for people who elect to proactively manage their health before any cardiac symptoms. This self-pay program allows anyone concerned about their heart health to be enrolled into the NCH-Caristo program.

"Patients will have the best opportunity to avert a heart attack here at NCH," said , Director of Preventive Cardiology, NCH Rooney Heart Institute. "This technology is built on world-class science and rigorous clinical research. It allows us to identify and address heart disease before it causes harm."

The collaboration coincides with Caristo Diagnostics' upcoming symposium at the American Heart Association (AHA) Scientific Sessions 2025, where experts including Drs. Orringer and Wang will discuss how imaging and AI are changing the way clinicians detect and manage coronary disease.



November 8, 2025
1:45–2:30 p.m.
Learning Studio 2, New Orleans, Louisiana

Caristo Diagnostics is a global leader in cardiovascular imaging and risk prediction, founded as a spin-out from the University of Oxford . Its award-winning technology helps detect hidden heart disease and identify people at risk of heart attack before symptoms appear. Working with leading hospitals, research institutions, and pharmaceutical partners, Caristo aims to save lives through early detection and personalized prevention. Learn more at or follow Caristo on LinkedIn, YouTube, Instagram, and X.

is an Advanced Community Healthcare System™ serving Southwest Florida with top-ranked hospitals, specialty care, and one of the largest provider networks in the region. Recognized by as one of America's Top 50 Hospitals and among the top three in Florida for cardiac care available at NCH Rooney Heart Institute, NCH delivers advanced medicine close to home. The system includes two hospitals with 713 beds and collaborations with the Hospital for Special Surgery, Nicklaus Children's Hospital, and others.
Visit for more information.

Photo: https://mma.prnewswire.com/media/2813085/NCH.jpg
Photo: https://mma.prnewswire.com/media/2813476/Caristo_Diagnostics_Analysis.jpg
Logo:  https://mma.prnewswire.com/media/2054669/5600589/Caristo_Logo.jpg

 

   

 

View original content:https://www.prnewswire.co.uk/news-releases/nch-becomes-first-us-hospital-to-use-ai-that-detects-hidden-heart-attack-risk-a-decade-in-advance-302604674.html

Ufficio Stampa
 PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom
Allegati
Non disponibili